4,4-Dimethyl-1,2,3,4-tetrahydroquinoline

CAS : 20364-31-2

Ref. 3D-VAA36431

Informations sur le produit

• Nom: 4,4-Dimethyl-1,2,3,4-tetrahydroquinoline
• Synonymes: 1,2,3,4-Tetrahydro-4,4-dimethylquinoline, 4,4-Dimethyl-1,2,3,4-Tetrahydroquinoline

Description

4,4-Dimethyl-1,2,3,4-tetrahydroquinoline (DMTH) is a synthetic compound that has been shown to stimulate pancreatic β-cells. DMTH is a prodrug that is converted into 4,4'-dimethoxy-1,2,3, 4-tetrahydroquinoline (DMT) by esterases in the body. DMT binds to the insulin receptor and increases insulin secretion from pancreatic β-cells. DMTH has been shown to be effective in treating patients with type 2 diabetes mellitus who are resistant to insulin. DMTH also reduces blood glucose levels in animal models of diabetes by stimulating the pancreas to produce more insulin and increasing the number of β cells in the pancreas. This drug may also prevent or reverse tissue damage caused by diabetes by inhibiting inflammatory processes and reducing oxidative stress on tissues.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 161.25 g/mol
• Formule: C₁₁H₁₅N
• Degré de pureté: Min. 95%
• Couleur/Forme: Clear Liquid